Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
Recruiting
Phase 1
Interventional Study
Recurrent Clostridioides Difficile Infection
Colonic Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 40 (estimated)
- Sponsor
- University of Minnesota · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single-center, open-label study for safety and feasibility of IMT in patients undergoing colonic surgery. After consent, individuals of the ages of 18-75 with a history of diverticulitis or sigmoid colon cancer will be enrolled to have a feeding tube placed at the time of surgery and receive IMT solution on postoperative day 2-3 (at least 48 hours following IV antibiotics) with the subse…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able/willing to provide informed consent
* Between 18-75 years of age
* Undergoing surgery for a history of diverticulitis or sigmoid colon cancer.
* Able to provide fecal samples
* Stated willingness to comply with all study procedures and availability for the duration of tri…
Contacts